Good comparison 8horse, a complication in the comparison though is Biogen’s takeover offer of $172usd/SH in July; now here’s also a kicker, NEU are now developing 2591 and readouts may be in December, if it’s early results are as good as rumored then NEU is cherry ripe for takeover offers; as I said earlier my current valuation is $24aud and that’s why I topped up on Friday.
I just dream that ASD and ADHD could be trialed in the future but alas I simply can’t see NEU existing that long.
Good comparison 8horse, a complication in the comparison though...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.65 |
Change
0.000(0.00%) |
Mkt cap ! $1.744B | |||
| Open | High | Low | Value | Volume |
| $13.70 | $13.76 | $13.56 | $3.689M | 270.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 37 | $13.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.66 | 1132 | 2 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |